Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.

Rodríguez Rodríguez, Mario; Castro Quismondo, Nerea; Zafra Torres, Denis; Gil Alos, Daniel; Ayala, Rosa; Martinez-Lopez, Joaquín

Rodríguez Rodríguez, Mario; Castro Quismondo, Nerea; Zafra Torres, Denis; Gil Alos, Daniel; Ayala, Rosa; Martinez-Lopez, Joaquín.

Rodríguez Rodríguez M; Department of Hematology, Hospital Universitario "12 de Octubre", Madrid, Spain.
Castro Quismondo N; Department of Hematology, Hospital Universitario "12 de Octubre", Madrid, Spain.
Zafra Torres D; Department of Hematology, Hospital Universitario "12 de Octubre", Madrid, Spain.
Gil Alos D; Department of Hematology, Hospital Universitario "12 de Octubre", Madrid, Spain.
Ayala R; Department of Hematology, Hospital Universitario "12 de Octubre", Madrid, Spain.
Martinez-Lopez J; Hematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.

Int J Lab Hematol ; 43(4): O152-O155, 2021 08.

Article in English | MEDLINE | ID: covidwho-1050346

Subject(s)

ADAMTS13 Protein/blood; COVID-19/blood; von Willebrand Factor/analysis; Blood Coagulation; Blood Coagulation Tests; COVID-19/diagnosis; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; SARS-CoV-2/isolation & purification

Keywords

ADAMTS13; COVID-19; coagulopathy; prognosis; von Willebrand factor

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Von Willebrand Factor / ADAMTS13 Protein / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Female / Humans / Male / Middle aged Language: English Journal: Int J Lab Hematol Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: Ijlh.13476

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google